Murray Anderson‐Hunt

1.6k total citations
14 papers, 1.3k citations indexed

About

Murray Anderson‐Hunt is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, Murray Anderson‐Hunt has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Biological Psychiatry and 3 papers in Pharmacology. Recurrent topics in Murray Anderson‐Hunt's work include Bipolar Disorder and Treatment (9 papers), Tryptophan and brain disorders (7 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Murray Anderson‐Hunt is often cited by papers focused on Bipolar Disorder and Treatment (9 papers), Tryptophan and brain disorders (7 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Murray Anderson‐Hunt collaborates with scholars based in Australia, Brazil and United States. Murray Anderson‐Hunt's co-authors include Ashley I. Bush, Ian Schapkaitz, David Copolov, Olivia Dean, Michael Berk, Sue Jeavons, Kristy Lu, Lorraine Dennerstein, Kristy Kohlmann and Philippe Conus and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and The Journal of Clinical Psychiatry.

In The Last Decade

Murray Anderson‐Hunt

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray Anderson‐Hunt Australia 12 665 644 171 171 165 14 1.3k
Ian Schapkaitz Australia 12 893 1.3× 743 1.2× 204 1.2× 229 1.3× 214 1.3× 14 1.5k
Denise R. Evans United States 12 327 0.5× 490 0.8× 301 1.8× 139 0.8× 58 0.4× 15 1.3k
Alessandra Solida Switzerland 11 281 0.4× 277 0.4× 180 1.1× 99 0.6× 107 0.6× 32 854
Fabiano A. Gomes Canada 16 573 0.9× 1.0k 1.6× 189 1.1× 158 0.9× 41 0.2× 38 1.6k
Lucas B. Rizzo Brazil 24 716 1.1× 764 1.2× 112 0.7× 283 1.7× 34 0.2× 40 1.8k
Russell E. Scheffer United States 16 352 0.5× 575 0.9× 71 0.4× 152 0.9× 89 0.5× 32 1.1k
Francesco Giorlando Australia 12 551 0.8× 751 1.2× 89 0.5× 145 0.8× 27 0.2× 14 1.4k
Jun Ku Chung Canada 20 274 0.4× 661 1.0× 251 1.5× 99 0.6× 35 0.2× 53 1.3k
Hitoshi Maeshima Japan 20 262 0.4× 240 0.4× 116 0.7× 109 0.6× 125 0.8× 35 806
Aida Santin Brazil 14 366 0.6× 788 1.2× 239 1.4× 118 0.7× 37 0.2× 20 1.2k

Countries citing papers authored by Murray Anderson‐Hunt

Since Specialization
Citations

This map shows the geographic impact of Murray Anderson‐Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Anderson‐Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Anderson‐Hunt more than expected).

Fields of papers citing papers by Murray Anderson‐Hunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray Anderson‐Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Anderson‐Hunt. The network helps show where Murray Anderson‐Hunt may publish in the future.

Co-authorship network of co-authors of Murray Anderson‐Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of Murray Anderson‐Hunt. A scholar is included among the top collaborators of Murray Anderson‐Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray Anderson‐Hunt. Murray Anderson‐Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2013). A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania. Australian & New Zealand Journal of Psychiatry. 47(6). 564–568. 48 indexed citations
2.
Dean, Olivia, Ashley I. Bush, David Copolov, et al.. (2012). Effects of N‐acetyl cysteine on cognitive function in bipolar disorder. Psychiatry and Clinical Neurosciences. 66(6). 514–517. 45 indexed citations
3.
Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 37(1). 132–135. 21 indexed citations
4.
Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). Dimensions of improvement in a clinical trial ofN-acetyl cysteine for bipolar disorder. Acta Neuropsychiatrica. 23(2). 87–88. 6 indexed citations
5.
Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2011). N-acetylcysteine for major depressive episodes in bipolar disorder. Brazilian Journal of Psychiatry. 33(4). 374–378. 94 indexed citations
6.
Berk, Michael, Olivia Dean, Gin S. Malhi, et al.. (2010). Qualitative Methods in Early-Phase Drug Trials. The Journal of Clinical Psychiatry. 72(7). 909–913. 23 indexed citations
7.
Magalhães, Pedro Vieira da Silva, Olivia Dean, Ashley I. Bush, et al.. (2010). N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial. Journal of Affective Disorders. 129(1-3). 317–320. 77 indexed citations
8.
Dodd, Seetal, Clarissa Severino Gama, David Copolov, et al.. (2009). Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial. Acta Neuropsychiatrica. 21(5). 239–245. 7 indexed citations
9.
Dodd, Seetal, Clarissa Severino Gama, David Copolov, et al.. (2009). Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial. Acta Neuropsychiatrica. 21(6). 285–291. 15 indexed citations
10.
Berk, Michael, David Copolov, Olivia Dean, et al.. (2008). N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial. Biological Psychiatry. 64(5). 361–368. 441 indexed citations
11.
Berk, Michael, David Copolov, Olivia Dean, et al.. (2008). N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial. Biological Psychiatry. 64(6). 468–475. 385 indexed citations
12.
Dennerstein, Lorraine, Murray Anderson‐Hunt, & Emma Dudley. (2002). Evaluation of a Short Scale to Assess Female Sexual Functioning. Journal of Sex & Marital Therapy. 28(5). 389–397. 60 indexed citations
13.
Anderson‐Hunt, Murray & Lorraine Dennerstein. (1995). Oxytocin and Female Sexuality. Gynecologic and Obstetric Investigation. 40(4). 217–221. 37 indexed citations
14.
Anderson‐Hunt, Murray & Lorraine Dennerstein. (1994). Drug points: Increased female sexual response after oxytocin. BMJ. 309(6959). 929.1–929.1. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026